|Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally?|
|Jump to Full Text|
|PMID: 23061054 Owner: NLM Status: PubMed-not-MEDLINE|
|The cytolethal distending toxins (CDTs) comprise a family of intracellular-acting bacterial protein toxins whose actions upon eukaryotic cells result in several consequences, the most characteristic of which is the induction of G(2)/M cell cycle arrest. Most CDTs are hetero-tripartite assemblies of CdtA, CdtB, and CdtC, with CdtB required for CDT-mediated cell cycle arrest. Several lines of evidence indicate that CdtA and CdtC are required for the optimal intracellular activity of CdtB, although the exact functional roles of CdtA and CdtC remain poorly understood. The genes encoding the CDTs have been identified in a diverse array of Gram-negative pathogenic bacteria. More recently, the genes encoding several CdtB subunits have been associated with alternatively linked subunits resembling the B-subunits of pertussis toxin. Although the CDTs are generally considered to all function as bacterial genotoxins, the extent to which individual members of the CDTs employ similar mechanisms of cell surface binding, uptake, and trafficking within sensitive cells is poorly understood. Recently, data have begun to emerge suggesting differences in the molecular basis by which individual CDTs interact with and enter host cells, suggesting the possibility that CDTs possess properties reflecting the specific niches idiosyncratic to those CDT bacterial pathogens that produce them. The extent to which functional differences between individual CDTs reflect the specific requirements for intoxicating cells and tissues within the diverse range of host microenvironments colonized by CDT-producing pathogenic bacteria remains to be experimentally explored.|
|Amandeep Gargi; Michael Reno; Steven R Blanke|
Related Documents :
|23852544 - The unique features of follicular t cell subsets.
23397394 - Molecular measurement of t cell receptor excision circles.
23871804 - Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocell...
23235274 - The g protein-coupled receptor gpr30 mediates the nontranscriptional effect of estrogen...
196064 - Electrical excitability of oat cell carcinoma.
3556764 - Growth and differentiation during myogenesis in the chick embryo.
|Type: Journal Article Date: 2012-10-08|
|Title: Frontiers in cellular and infection microbiology Volume: 2 ISSN: 2235-2988 ISO Abbreviation: Front Cell Infect Microbiol Publication Date: 2012|
|Created Date: 2012-10-12 Completed Date: 2012-10-15 Revised Date: 2013-02-11|
Medline Journal Info:
|Nlm Unique ID: 101585359 Medline TA: Front Cell Infect Microbiol Country: Switzerland|
|Languages: eng Pagination: 124 Citation Subset: -|
|Department of Microbiology, Institute for Genomic Biology, University of Illinois Urbana, IL, USA.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Front Cell Infect Microbiol
Journal ID (iso-abbrev): Front Cell Infect Microbiol
Journal ID (publisher-id): Front. Cell. Inf. Microbio.
Publisher: Frontiers Media S.A.
Copyright © 2012 Gargi, Reno and Blanke.
Received Day: 01 Month: 4 Year: 2012
Accepted Day: 17 Month: 9 Year: 2012
Electronic publication date: Day: 08 Month: 10 Year: 2012
collection publication date: Year: 2012
Volume: 2E-location ID: 124
PubMed Id: 23061054
|Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally?|
|Steven R. Blanke*|
|Department of Microbiology, Institute for Genomic Biology, University of IllinoisUrbana, IL, USA
|[edited-by] Edited by: Ken Bradley, University of California, Los Angeles, USA
[edited-by] Reviewed by: Stephanie M. Seveau, The Ohio State University, USA; Teresa Frisan, Karolinska Institutet, Sweden
Correspondence: *Correspondence: Steven R. Blanke, B103 CLSL, 601 South Goodwin Avenue, Urbana, IL 61801, USA. e-mail: email@example.com
Pathogenic bacteria have acquired attributes that promote adaptation to the specific and often diverse environments encountered within the host. Successful pathogens often actively alter, or remodel, host cells and tissues in order to create a more suitable niche for colonization, often through the direct action of bacterial protein toxins and effectors (Blanke, 2006).
A diverse group of Gram-negative pathogenic bacteria target and modulate the eukaryotic cell cycle through the action of the cytolethal distending toxins (CDTs). Several lines of evidence support the idea that CDTs functions as genotoxins by inducing DNA lesions that ultimately result in cell cycle arrest and cytotoxicity. Current models for both the mechanisms underlying CDT action, as well as the cellular responses to intoxication, have been derived primarily from the study of CDTs from just several toxin-producing species of pathogenic bacteria. However, the discovery of broad carriage of the genes encoding CDTs across many Gram-negative bacteria, as well as the sequence variance between CDTs challenges the notion that individual members within this broad family of these toxins each bind, enter, and deliver their toxic moiety into host cells by an identical mechanism.
The CDTs were discovered approximately 25 years ago as heat labile factors within culture filtrates of enterotoxigenic E. coli (Johnson and Lior, 1988a) and Campylobacter spp. (Johnson and Lior, 1988b) that induced dramatic and progressive distention of many, but not all, mammalian cell lines. In the decades that have followed their initial discovery, CDTs have been associated with Gram-negative pathogenic bacteria that occupy a diverse array of host niches, including the urogenital tract and the oral cavity. A variety of Gram-negative pathogenic bacteria produce CDTs, including Aggregatobacter actinomycetemcomitans (Aa-CDT), Campylobacter jejuni (Cj-CDT), Escherichia coli (Ec-CDT), Haemophilus ducreyi (Hd-CDT), Helicobacter hepaticus (Hh-CDT), and Shigella dysenteria (Sd-CDT). But how widely found are the CDTs?
From the mid 1990s and into the early 2000s, the methods for identifying CDT-producing Gram-negative pathogenic bacteria morphed from primarily phenotypic observations of toxin-mediated distention of cultured mammalian cells to genotyping strains for the presence of the genes encoding CDT. The true molecular nature of CDT was revealed from sequencing CDT-encoding regions from enteropathogenic E. coli (EPEC) (Scott and Kaper, 1994) and enterotoxigenic E. coli (ETEC) (Pickett et al., 1994), which revealed the presence of three open reading frames (designated cdtA, cdtB, and cdtC) organized within a 3-gene operon (Figure 1). Although, widely conserved among CDT-producing pathogens, exceptions to the overall cdtA/cdtB/cdtC gene structure have been identified. Most notably, a distinct CDT with cdtB conserved, but having cdtA and cdtC substituted with genes encoding two homologs of the pertussis toxin (Figure 2) has been described in Salmonella enterica serovar Typhi (S. typhi) (Spanò et al., 2008), and will be considered separately below.
To obtain insights into the evolutionary and functional relationships between the proteins encoded by these genes, we examined the phylogenetic relationships between the CDT family members using an expanded set of sequences from the NCBI non-redundant protein database, which currently (accessed February 23, 2012) contains 690, 584, and 695 protein sequences annotated to encode CdtA, CdtB, and CdtC, respectively. Phylogenetic analysis revealed a high level of diversity among individual cdt genes (Figure 2), consistent with a previous published phylogenetic analysis (Degnan and Moran, 2008). Collectively, 32 species of bacteria and 2 bacteriophages were identified to have genes annotated to encode at least one CDT subunit. Interestingly, the cdt genes identified from the current database were restricted to members of the γ-Proteobacteria and ε-Proteobacteria, consistent with earlier reported results (Degnan and Moran, 2008).
The individual phylogenies for each subunit of CDT resolve similar relationships indicating that evolution has occurred largely in the form of vertical descent but is punctuated with occasional instances of horizontal gene transfer adding complexity to the evolutionary history (Ochman et al., 2000). The presence of CDT subunits on bacteriophage further supports this proposal of lateral gene transfer events.
Examination of the phylogenies (Figure 2) reveals that the species of the genus Yersinia possess the most unique sequence types of CDT found in the NCBI databases. The branch leading to a Yersinia species was the longest branch in each of the three phylogenies indicating that this branch may represent the most ancestral form, or, that evolution of CDT has accelerated along the Yersinia lineage (Aguileta et al., 2009). If Yersinia does represent the most ancestral form of CDT, these phylogenetic analyses would indicate that CDT originated in the γ-Proteobacteria and was later horizontally transferred into the ε-Proteobacteria based on the evolutionary relationships seen in 16S rRNA phylogenies (Ciccarelli et al., 2006; Yarza et al., 2010). The factors that restrict transfer of genes encoding the CDTs to only species of the γ-Proteobacteria and the ε-Proteobacteria are not clear.
Inconsistencies between the phylogenies for each subunit of CDT are most likely the result of instances of horizontal gene transfer. The species of Yersinia represent the most apparent examples. In the case of Y. ruckeri, CdtA shows more similarity to the more recently diverged Haemophilus/Aggregatibacter and Escherichia dominated clades. In Y. enterocolitica, CdtC shows a closer relationship to the Haemophilus/Aggregatibacter clade than to other Yersinia sequences. As a member of the γ-Proteobacteria, the CdtB sequence of H. chejuensis is likely a result of horizontal gene transfer. H. cinaedi represents an example of horizontal gene transfer between two closely related genera. Phylogenetically, CDT from H. cinaedi is more similar to the C. fetus II clade than the Helicobacter clade. Although H. cinaedi was recently reclassified as a Helicobacter species after initial classification as a Campylobacter species (Vandamme et al., 1991), it would be expected to be most similar to H. bilis based on the 16S rRNA phylogeny (Solnick and Vandamme, 2001). An interesting example of horizontal gene transfer within only one of the three CDT genes was found for C. lari, which is broken into three distinct clades for CdtC, while only a single clade with one outlier is observed in both CdtA and CdtB.
Although absent from the CdtB phylogeny (Figure 2), both Y. ruckeri and Y. bercovieri possess a homolog to CdtB; however, these Y. ruckeri and Y. bercovieri sequences shared only 30% identity with Y. enterocolitica CdtB and were far below the cut-offs used when searching the NCBI database with a reference set of CDT sequences. The published genome of Hahella chejuensis revealed the presence of highly divergent CdtA and CdtB subunits that were most similar to those found in the Yersinia, but these proteins were also excluded from the phylogenetic analyses due to unreliability of their alignment to other CDT sequences. For Helicobacter mastomyrinus and H. callitrichis, no sequenced version of CdtA or CdtC was available. Sequences with similarities to CdtA or CdtC were identified within the carboxyla-termini of several Pseudomonas entomophila open reading frames. However, these proteins also contained regions of greater than a hundred additional residues lacking sequence similarity to either CdtA or CdtC, and these sequences were excluded from the phylogenetic analyses.
The CdtB sequence has also been detected in multiple variants of the APSE bacteriophage that apparently lack the genes encoding either CdtA or CdtC (Moran et al., 2005). APSE are lysogenic phages that have been found to infect “Canditatus Hamiltonella defensa” which is a facultative endosymbiont of numerous sap-feeding insects. The presence of APSE has been linked with the aphid possessing increased resistance against parasitoid wasps (Oliver et al., 2005). Unlike S. enterica Typhi, no alternative receptor-binding subunits have been detected (Degnan and Moran, 2008). While the method of delivery of CdtB originating from APSE remains unknown, it has been proposed that the “Ca. Hamiltonella defensa” type two secretion system, type three secretion system, or lysis of intracellular endosymbiont cells may be factors in delivery (Degnan and Moran, 2008). Evolutionarily, the presence of CdtB on APSE phages provides both another example of a vector to facilitate horizontal gene transfer as well as an example of co-option of this toxin by a symbiont to provide a better fitness advantage to its host.
The presence of a Salmonella clade in the CdtB phylogeny led to a hypothesis of modularity between CdtB and receptor-binding subunits (Spanò et al., 2008). The CdtB sequences found within that clade do not adhere to the canonical association of CdtA, CdtB, and CdtC found in other species. Instead, these CdtB sequences are found in a small pathogenicity island associated with homologs to the pertussis toxin receptor-binding subunits A and B. Previous studies have hypothesized that these pertussis toxin B-fragment homologs in S. enterica Typhi may functionally substitute for CdtA and CdtC found in almost all other species (Spanò et al., 2008). Interestingly, our analyses revealed the substitution of the pertussis toxin B-fragment homologs for the canonical CdtA and CdtC subunits within the published genomes of both S. enterica arizonae as well as S. bongeri. Additionally, potential homologs to both pertussis subunits were found by BLAST in E. coli and Y. enterocolitica; however, they were not present in same configuration as is seen in Salmonella. Finally, it is noteworthy that S. enterica arizonae possess distinct copies of both “types” of CDTs. However, the predicted CdtB protein sequence in the “canonical” cdtA/cdtB/cdtC operon is truncated by over 100 amino acid residues.
Taken together, these phylogenetic analyses reveal the emergence of distinct CDT subfamilies, characterized by a high degree of sequence diversity existing among the three subunits. The extent to which this sequence diversity reflects true functional differences between CDTs is largely unexplored. However, as discussed below, several studies have recently hinted at striking dissimilarities in the potencies of CDTs from several different species, as well as the requirement for distinct host determinants required for intoxication, suggesting that individual CDTs may bind, enter, and traffic within host cells in fundamentally different ways.
Intracellular-acting bacterial protein toxins generally possess a two-component “AB” functional architecture (Blanke, 2006). The B components facilitate toxin binding and uptake into sensitive host cells, whereas the A components, which are typically enzymes, act upon specific intracellular targets in a manner that alters or disrupts normal cellular function. Several subclasses of AB toxins can be differentiated based on the number and/or arrangement of the A and B subunits. Diphtheria toxin and exotoxin A from Pseudomonas aeruginosa are single-chain AB toxins, whose A and B components are encoded within a single polypeptide that are ultimately separated following proteolysis and reduction of a bridging disulfide linkage. Cholera and pertussis toxins are members of the AB5 subclass, characterized by either homo- or hetero-B-fragment pentamers that assemble non-covalently with the catalytic A fragments prior to secretion. Anthrax toxin is a member of a third AB toxin subclass called the binary toxins, comprising separately secreted A and B polypeptides that assemble on the surface of mammalian cells. As discussed below, CDTs may comprise a 4th subclass of AB intracellular-acting toxins.
Several studies have indicated that CdtA, CdtB, and CdtC assemble into a heterotrimeric complex (Lara-Tejero and Galan, 2001; Saiki et al., 2001, 2004; Wising et al., 2002; Nesiæ et al., 2004; Shenker et al., 2004; Cao et al., 2005, 2008; Nesic and Stebbins, 2005; Hu and Stebbins, 2006; Yamada et al., 2006). The maximal potency of CDTs on mammalian cells is generally believed to require the involvement of all three subunits. In fact, several studies have reported that the presence of CdtA, CdtB, and CdtC are absolutely required for Hd-CDT (Lara-Tejero and Galan, 2001; Saiki et al., 2001), Aa-CDT (Wising et al., 2002; Nesiæ et al., 2004; Shenker et al., 2004), and Cj-CDT (Saiki et al., 2004; Cao et al., 2005; Nesic and Stebbins, 2005) to induce cell cycle arrest within intoxicated cells.
In contrast, several studies have indicated that CdtA is not absolutely required for CDT activity. Mixtures of Aa-CdtB/Aa-CdtC retained the capacity to induce G2/M cell cycle arrest in the absence of Aa-CdtA (Cao et al., 2005, 2008; Hu and Stebbins, 2006; Yamada et al., 2006). Similarly, mixtures of recombinant Hd-CdtB and Hd-CdtC induced cell elongation characteristic of CDT-intoxicated cells, although the activity was enhanced in the presence of periplasmic extracts containing Hd-CdtA (Deng et al., 2001). In another study, whole-cell sonicates produced from mutant strains of H. ducreyi lacking the cdtB or cdtC genes exhibited a loss of cytotoxic activity toward HeLa cells, whereas the sonicate from the cdtA mutant retained cytotoxic activity, albeit at a slightly reduced level (Lewis et al., 2001). For Cj-CDT, combinations of recombinant CdtB and CdtC were only approximately 4-times less potent that mixtures of all three subunits in their capacity to induce cell cycle arrest (Lee et al., 2003).
A more thorough understanding of the specific contributions of the CdtA or CdtC subunits to the potency and action of CDT holotoxins will require the systematic comparison of quantitative dose response curves derived from binary combinations of CDT subunits versus those derived from the corresponding heterotrimeric toxin assemblies.
The first indications that CDTs function as intracellular-acting toxins were studies reporting that the cell cycle modulatory activity of Hd-CDT is inhibited when clathrin-mediated endocytosis is blocked (Cortes-Bratti et al., 2000), suggesting that the toxin must be internalized from the cell surface into cells to induce G2/M cell cycle arrest. Additional evidence for an intracellular site of action came from transient expression or microinjection (Lara-Tejero and Galan, 2000) of Cj-CdtB, or electroporation (Elwell et al., 2001) of Ec-CdtB alone in mammalian cells, suggesting the enzymatic activity resides within the CdtB subunit of the holotoxin. Moreover, expression of Cj-CdtB alone in yeast also induced G2/M arrest (Hassane et al., 2001), analogous to what happens in mammalian cells. Using in vitro DNA degradation assays, two groups demonstrated independently that CdtBs from either E. coli and C. jejuni possess DNase I activity (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000). Mutations in CdtB residues predicted to be functionally equivalent to those in type I DNases required for catalysis or magnesium-binding ablated DNase activity (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000).
Interestingly, several studies have reported intracellular toxin activity associated with the CdtC subunit. CdtC was necessary for G2 arrest in human T cells that had been exposed to Aa-CDT with a defective mutant form of the CdtB subunit (Shenker et al., 2000). In addition, protein transfection of CHO cells with recombinant forms of either Aa-CdtB or Aa-CdtC alone induced cellular elongation and cell death (Mao and DiRienzo, 2002).
The capacity of CDT to induce cellular responses normally associated with DNA damage suggests that the ultimate site of CdtB action is the nucleus. In support of this model, the introduction of Ec-CdtB directly into mammalian cells by either electroporation or ectopic overexpression revealed enrichment of CdtB within the nuclear region and G2/M cell cycle arrest (McSweeney and Dreyfus, 2004). Mutant forms of the Ec-CdtB lacking putative nuclear localization signals were deficient in nuclear localization and the capacity to induce G2/M arrest (McSweeney and Dreyfus, 2004). For Aa-CdtB, deletion of a non-canonical amino-terminal nuclear localization sequence prevented intoxication (Nishikubo et al., 2003). Nonetheless, the capacity of the CdtB subunit to localize to the nucleus of cells that have taken up holotoxin from the cell surface remains to be demonstrated.
The discovery of Cj-CdtB (Lara-Tejero and Galan, 2000) and Ec-CdtB (Elwell and Dreyfus, 2000) catalytic residues conserved with eukaryotic DNase I, first suggested that this CDT subunit might function as an intracellular-acting DNase. High resolution structural data support this idea, as structures for Hd-CdtB (Nesiæ et al., 2004), Aa-CDT (Yamada et al., 2006), and Ec-CdtB (Hontz et al., 2006) possess the canonical four-layered fold of the DNase I family, which is a central 12-stranded β-sandwich packed between outer α-helices and loops on each side of the sandwich. In vitro DNase I activity, albeit relatively poor, has been demonstrated for purified CdtB subunits from several bacteria (Elwell and Dreyfus, 2000). Directed mutagenesis of CdtB active site residues predicted by sequence homology to be important for the catalytic activity or the Mg2+-binding resulted in inactive forms of CdtB deficient in DNA cleavage activity and in the capacity to induce DNA damage responses leading to cell cycle arrest (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000; Hassane et al., 2001; Guerra et al., 2005). In yeast, ectopic expression of Cj-CdtB was demonstrated to induce homologous recombination and activation of DNA damage checkpoints, which are characteristic mechanisms of cellular responses to DNA damage (Kitagawa et al., 2007).
There is not universal agreement that the cellular effects associated with CDT intoxication are due to the DNA degrading activity of the CdtB subunit. Indeed, sequence homology of CdtBs with members of a broad metalloenzyme superfamily led to the proposal that CdtB induces cell cycle arrest as a phosphatase rather than a DNase (Dlakic, 2001). Support for this hypothesis emerged from studies reporting that in vitro, Aa-CdtB demonstrates PI-3,4,5-triphosphate phosphatase activity (Shenker et al., 2007). Mutant proteins with altered residues known to be important for phosphatase activity ablated the in vitro activity of Aa-CdtB, as well as the capacity of Aa-holotoxin to induce G2/M arrest in human lymphocytes.
To date, phosphatase activity has not been reported for any CDT other than Aa-CDT. Several studies have reported data suggesting that at least some of the cellular consequences of Aa-CDT cellular intoxication are not likely due to phosphatase activity of Aa-CdtB. Ectopic expression of Aa-CdtB in Saccharomyces cerevisiae-induced DNA damage and S/G2 cell cycle arrest, although yeast does not possess the substrate for the reported Aa-CdtB phosphatidylinositol-3,4,5-triphosphate phosphatase activity (Matangkasombut et al., 2010). Moreover, Aa-CDT-mediated apoptosis in proliferating U937 monocytes was demonstrated to depend solely on the DNase activity of the Aa-CdtB subunit (Rabin et al., 2009). The phosphatidylinositol-3,4,5-triphosphate phosphatase activity is not likely to be idiosyncratic for Aa-CdtB, as this subunit shares a nearly identical sequence to that of the CdtB subunit from H. ducreyi (Hd-CdtB).
The cellular studies cited above strongly support the idea that CdtB functions as the enzymatically active A component of an intracellular-acting toxin. But what about CdtA and CdtC? The canonical role of a toxin's B component is to bind the toxin to the cell surface and facilitate intracellular transport and/or translocation of the catalytic A moiety out of the vesicle trafficking network to access the toxins intracellular target (Blanke, 2006). As discussed above, there are conflicting reports as to the essentiality of CdtA for toxin cellular activity, suggesting that perhaps CdtC functions as the toxin B fragment. Indeed, this notion is supported by independent reports of cellular cytotoxicity associated with CdtB/CdtC alone (albeit requiring higher concentrations than the tripartite holotoxin). However, the sufficiency of CdtB/CdtC for cytolethal distending activity has not been a universal finding. Moreover, reports of cellular cytotoxicity associated with CdtC alone further muddy our understanding of the structure and function of the CDTs.
High-resolution structural data have provided some clues, with the CdtA and CdtC subunits of the Hd-CDT holotoxin bearing structure homology with lectin-like proteins, including the B-fragment repeats of the plant toxin, ricin (Nesiæ et al., 2004). The importance of CdtA and CdtC for toxin binding and uptake from the cell surface has directly been demonstrated in several functional studies (Lee et al., 2003; McSweeney and Dreyfus, 2004, 2005). Fluorescence imaging indicated that Aa-CdtA alone binds on the surface of CHO cells to the same extent as a mixture of all three CDT subunits, and better than Aa-CdtB or Aa-CdtC alone (Mao and DiRienzo, 2002). Cj-CDT was demonstrated to bind to the surface of HeLa cells in a saturable manner (Lee et al., 2003). The CdtA and CdtC subunits both bound to the surface of HeLa cells, while CdtB demonstrated little binding to the cell surface. Using a CELISA, the competition-binding assays revealed that both CdtA and CdtC bound to the surface of cells in a specific manner. However, defining the relative contributions of CdtA and CdtC to binding CDT to the cell surface awaits additional study.
An interesting exception to the CdtA/CdtB/CdtC tripartite structure characteristic of the CDT superfamily was discovered within S. enterica, serovar Typhi CDT (St-CDT) (Haghjoo et al., 2004), for which the gene encoding CdtB is not associated with genes resembling cdtA or cdtC. Instead, the cellular modulatory activity of St-CDT is dependent upon expression of two genes, pltB (pertussis-like toxin B) and pltA (pertussis-like toxin A) (Figure 1), which encode proteins resembling the B components of pertussis toxin, an unrelated AB5-intracellular-acting toxin. The reconstituted CdtB/PltA/PltB tripartite complex was demonstrated to induce DNA damage within intoxicated eukaryotic cells (Spanò et al., 2008). Infection studies revealed that bacterial uptake into host cells triggers expression of cdtB/pltA/pltB, and that the PltB and PltA subunits are required for transport of intracellular St-CDT to the extracellular medium, where St-CDT then acts upon uninfected host cells in a paracrine manner (Spanò et al., 2008). Such a mechanism has not been previously described for any AB-toxin, and suggests an expanded role beyond the canonical functions normally associated with the B components of intracellular-acting toxins.
As intracellular-acting genotoxins, the CDTs have several fundamental problems to solve in order to exert their modulatory activities, with the most glaring being how to transport soluble CdtB moieties from the cell surface to the nucleus. There are some recent indications, as discussed below, that host cell requirements for the genotoxic activity of CDTs from different species may be divergent, raising the possibility that not all CdtB moieties travel from the cell surface to the nucleus along a single transport pathway.
Cell surface binding and intoxication by several CDTs have been reported to require toxin binding to cholesterol/sphingomyelin-rich microdomains within the outer leaflet of the plasma membrane called membrane rafts. Aa-CDT (Boesze-Battaglia et al., 2006) binds to GM1-enriched regions of the plasma membrane, which are characteristic of membrane rafts. Cholesterol depletion reduces the ability of both Aa-CDT (Boesze-Battaglia et al., 2006) and Hd-CDT (Guerra et al., 2005) to bind to the surface of sensitive cells, and prevents intoxication. Finally, mammalian cell lines with an inactivated SGMS1 gene, resulting in reduced levels of the key raft component sphingomyelin, were relatively resistant to Ec-CDT (Carette et al., 2009). Although the functional significance of CDT association with membrane rafts is not fully appreciated, toxin binding may be important for uptake into cells, as one of cellular functions associated with rafts is the clustering of the molecular machinery associated with endocytosis.
The presence or absence of receptors on the plasma membrane surface often dictates the sensitivity or resistance, respectively, of host cells to specific intracellular-acting bacterial toxins (Blanke, 2006). Using ligand blotting assays, very early studies reported the binding of partially purified Cj-CDT to two peptides with approximate molecular masses of 45 and 59 kDa from HeLa cell membrane preparations and 59 kDa from CHO cell membrane preparations (Bag et al., 1993), suggesting the presence of molecular components on the surface of host cells that might function as CDT receptors.
To date, bonafide CDT receptors have not yet been identified. One study implicated fucose as an important determinant for Ec-CDT, as lectins targeting fucose moieties-inhibited toxin interactions with cells to a greater extent than lectins targeting alternative glycans (McSweeney and Dreyfus, 2005). Another study indicated that the Aa-CDT holotoxin binds to surface glycosphingolipids, and that inhibitors of glycosphingolipid synthesis can prevent intoxication of the human monocytic U937 cell line (Mise et al., 2005). Mutagenesis of a human cell line haploid for most chromosomes identified cell lines deficient in the membrane-expressed protein TMEM181 that were resistant to Ec-CDT, although it is not yet clear that TMEM181 functions as a cell surface receptor for this toxin (Carette et al., 2009).
A recent study in which Aa-CDT, Cj-CDT, Ec-CDT, and Hd-CDT were compared in a head to head fashion revealed considerable differences in the potencies of these toxins, as well as the target cell requirements important for intoxication (Eshraghi et al., 2010). For example, cholesterol was found to be important for the cellular activities of Aa-CDT, Cj-CDT, and Hd-CDT, but not for those of Cj-CDT. Using mutant CHO cell lines lacking N-linked complex- or hybrid-carbohydrates, glycosphingolipids, or fucose, the study also reported the unexpected finding that, N- and O-glycan, or fucosylated structures are in fact not required for mediating toxin binding (Eshraghi et al., 2010). The diversity of cell surface determinants important for CDT interactions identified in these early studies suggest that individual CDTs may each bind to a different receptor. It is attractive to speculate that CDT receptor diversity reflects the tissue tropism of individual CDT-producing pathogens.
Receptor-binding not only concentrates toxins on the surface of host cells, but also positions bound toxin molecules to exploit existing cellular mechanisms for uptake of proteins into cells (Blanke, 2006). Several studies indicate that CDTs are rapidly taken up from the cell surface into an intracellular compartment, suggesting that these toxins are internalized by an endocytic-like mechanism. In support of this idea, Hd-CDT-mediated cell cycle arrest was demonstrated to be dependent on dynamin (Cortes-Bratti et al., 2000), which contributes to several overall mechanisms of endocytosis.
For CDT to function as a genotoxin, the CdtB subunit must escape degradation within the endocytic trafficking pathway and localize to the nucleus. Biochemical and fluorescence imaging studies suggest that CDTs are transported in a retrograde manner from the endo-lysosomal system to the ER via the Golgi complex (Guerra et al., 2005) (Figure 3). Analogous to several other toxins, including cholera and Shiga toxins, the catalytically active subunit (CdtB) is believed to be translocated from the ER to the cytosol by exploiting the ER degradation pathway, which normally translocates misfolded proteins to the cytosol via protein translocons within the ER membrane (Blanke, 2006). One study reported that Hd-CdtB was not detected within the cytosol of intoxicated cells (Guerra et al., 2009). In fact, to date, there is no experimental evidence that any CDT subunit is translocated from the ER to the cytosol of intoxicated cells, leading to the suggestion that the CdtB subunits may be translocated directly from the ER to the nucleus (Guerra et al., 2009).
Clearly, a major gap in the mechanism underlying CDT-mediated cellular intoxication is how CdtB reaches its site of action. As discussed above, the putative nuclear localization signals identified for two members of the CDT family, Aa-CDT and Ec-CDT, are highly divergent, suggesting that the mechanisms by which these two toxins are transported to the nucleus are not necessarily identical.
The designation of CDT as a genotoxin derives from the demonstration that isolated CdtB (1) functions as a DNase in vitro (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000), (2) induces nuclear fragmentation and chromatin disruption when transfected in cultured mammalian cells or Saccharomyces cerevisae (Hassane et al., 2001), and, (3) promotes DNA fragmentation in cells intoxicated with exogenously added CDT (Frisan et al., 2003). CDT-mediated insults to genome integrity induces cellular responses geared toward the repair of DNA lesions and cell survival.
Most (yet not all) of the experimental evidence to date suggests that the cellular modulatory activity of CDTs originates from toxin-mediated DNA damage, which activates the cellular DNA repair machinery. CDT-dependent DNA damage induces the recruitment of the DNA damage sensor complex MRN and the ATM kinase, which phosphorylates H2AX, a member of the histone 2A family, and activation of several DNA damage checkpoint responses. Several studies have demonstrated that activation of kinase CHK2 leads to inactivation of the CDC25 phosphatase, resulting in the accumulation of the hyperphosphorylated (and inactive) form of the cyclin-dependent kinase CDK1 (pCDK1), leading ultimately to arrest at the G2/M interface (Sert et al., 1999; Cortes-Bratti et al., 2001; Li et al., 2002; Sato et al., 2002; Yamamoto et al., 2004; Cuevas-Ramos et al., 2010), and in some cases, transition into a senescent state (Blazkova et al., 2010). A second consequence of CDT-dependent DNA damage is activation of the tumor suppressor p53 and its downstream effector p21, leading to cell cycle arrest at the G1/S checkpoint in this case.
CDT-dependent apoptosis has been reported in many cell types. In general, CDT intoxication of cells of non-haematopoietic origin results in cell cycle arrest preceding apoptosis (Jinadasa et al., 2011). In contrast, CDT intoxication of haematopoietic cells results in rapid apoptosis, indicating differential cellular responses to the action of CDTs.
While CDT-intoxicated cells have been demonstrated to undergo apoptosis, there are reports that in some cases, CDTs also mobilize cell survival pathways. The survival of CDT intoxicated cells is dependent on the activation of the small GTPase RhoA (Frisan et al., 2003), which induces actin stress fiber formation, and prevents cell death via activation of the mitogen-activated protein kinase p38 and its downstream target mitogen-activated protein kinase-activated protein kinase 2 (Guerra et al., 2008). The activation of RhoA is dependent on the dephosphorylation of the RhoA-specific guanine nucleotide exchange factor Net1, and it appears to be part of the DNA damage repair responses because it requires a functional ATM (Guerra et al., 2008).
Factors that disrupt normal cell cycle progression may promote acquisition of the cancerous phenotype. While CDT clearly is a modulator of the cell cycle, does the action of this genotoxin during infection contribute to the development of a cancerous phenotype?
Infection with pathogenic bacteria has increasingly been associated with malignant disease in humans. However, when considering putative risk factors for cancer, the leap from association to causality can be perilous. How might persistent bacterial infection increase cancer risk? The evolution of pre-malignant to cancerous cells is often characterized by a “mutator phenotype” in which mutations accumulate at an accelerated rate, resulting in genomic instability (Raptis and Bapat, 2006). One of the ways that bacterial infections are thought to promote acquisition of the mutator phenotype is the establishment of a chronic pro-inflammatory microenvironment.
How might persistent bacterial infections induce inflammatory microenvironments? During chronic infection, host tissues are constantly exposed to bacterial PAMPs, which are sensed by pattern recognition receptors (e.g., Toll-like receptors) (Grivennikov et al., 2010). Sustained activation of pattern recognition receptors results in elevated levels of pro-inflammatory cytokines, as well as reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI), which are genotoxic agents that increase the rate and incidence of mutations (Vogelmann and Amieva, 2007).
The most extensively studied association of pathogen-dependent establishment of pro-inflammatory microenvironments and cancer is the increased risk of gastric adenocarcinoma in those individuals infected with H. pylori (Polk and Peek, 2010). Notably, chronic H. pylori infection correlate with a significant (5-fold) increase in mutation frequency and microsatellite instabilities within the gastric epithelium of infected mice (Touati et al., 2003). Other examples are chronic carriage of S. enterica, serovar Typhi, and Bacteroides fragilis, which have been associated with gallbladder and colon cancers, respectively (Toprak et al., 2006; Vogelmann and Amieva, 2007). Moreover, Streptococcus bovis with colon cancer, Chlamydia pneumoniae with lung cancer, and Bartonella species with vascular tumor formation (Vogelmann and Amieva, 2007).
The contributions, if any, of CDTs to the development of human malignancies are largely unexplored. Analogous to genotoxic agents such as ROS and RNI that increase the rate of mutations within the genome (Karin et al., 2006; Grivennikov et al., 2010), one possibility is that CDT might contribute to progressive genome destabilization within the pathogen-induced pro-inflammatory microenvironments (Grivennikov et al., 2010). CDT activation of survival responses in cells harboring DNA damage could contribute to the accumulation of genetic instability within the developing inflammatory micro-environment, which may constitute the perfect storm of conditions for promoting the transformation of pre-neoplastic cells to malignant cells in the host.
Several studies have begun to address whether infection with CDT-producing pathogenic bacteria may induce changes in the host associated with an early neoplastic process. Using NF-κB-deficient mice to study persistent C. jejuni infection, one study indicated a proinflammatory role for Cj-CDT in vivo, as toxin-producing strains were associated with significantly enhanced severity of gastritis and significantly higher occurrence of gastric hyperplasia and dysplasia, which are markers of an early neoplastic process (Fox et al., 2004). For Helicobacter hepaticus, which causes chronic hepatitis and typhlocolitis in some mice, CDT was demonstrated to be critical for persistent infection of Swiss Webster mice, which is characterized with severe inflammation (Ge et al., 2005). In another study, H. hepaticus infection of A/JCr mice demonstrated a significantly higher inflammatory response in strains producing Hh-CDT than isogenic mutant strains. (Ge et al., 2007). The presence of CDT was associated with a progression of inflammation to dysplasia. In the future, it will be important to conduct studies that will evaluate potential associations between CDT-dependent dysplasia and toxin-mediated DNA damage, chronic induction of DNA damage repair pathways, and the acquisition of the type of genomic instability preceding acquisition of the mutator phenotype discussed above.
One cannot help but be fascinated by the vertical transmission of phenotypic traits within families that can result in strikingly similar appearance and mannerisms. But, as is often the case when we dig below the surface, interesting and important differences emerge which define the unique identity of individual family members.
When considering the “CDT family,” a natural focus has centered on the similarities among the individual members, and to figure out, in essence, how they “look alike.” Most of the excellent work that has been conducted thus far, by many different laboratories, to identify and characterize the structure-function relationships and intoxication properties has appropriately focused on just several CDTs (e.g., Aa-CDT, Cj-CDT, Ec-CDT, and Hd-CDT). The conclusions from studying this small subset of the CDT family have been extended rather generically across the broader family of CDTs. Yet, neither the structure-function relationships nor the mechanisms underlying cellular intoxication of cells by the vast majority of CDTs have been examined. In fact, the striking diversity in the sequences of CDT subunits identified in an increasing number of genomes of bacterial species from the γ-Proteobacteria and ε-Proteobacteria suggest that the extent to which individual CDTs function in a similar fashion should be reexamined.
The degree to which the large sequence diversity among CDTs reflects functional differences between individual members of the CDT family is largely unexplored. Nonetheless, as discussed above, there are some hints from several recent studies that CDTs may in fact be highly divergent in their potencies and specific host requirements for intoxication. It will be interesting to test the premise that the functional differences between CDTs may reflect the diversity of host cells and tissues that compromise the infection microenvironments targeted by CDT-producing pathogenic bacteria.
One of the true challenges in the CDT field is to understand the in vivo consequences of CDT action during infection. Studies to understand, from an evolutionary perspective, the benefit of CDT-mediated genotoxicity for promoting host-pathogen interactions, remain a particular challenge, because any benefits may in fact be highly idiosyncratic to the specific pathogen and the host niche occupied by that pathogen.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We acknowledge research support (NIH R01 GM0908756). We offer our apologies to those investigators whose work we were unable to cite.
|Aguileta G.,Refrégier G.,Yockteng R.,Fournier E.,Giraud T.. (Year: 2009). Rapidly evolving genes in pathogens: methods for detecting positive selection and examples among fungi, bacteria, viruses and protists. Infect. Genet. Evol. 9, 656–67010.1016/j.meegid.2009.03.01019442589|
|Bag P. K.,Ramamurthy T.,Nair U. B.. (Year: 1993). Evidence for the presence of a receptor for the cytolethal distending toxin (CLDT) of Campylobacter jejuni on CHO and HeLa cell membranes and development of a receptor-based enzyme-linked immunosorbent assay for detection of CLDT. FEMS Microbiol. Lett. 114, 285–2918288105|
|Blanke S. R.. (Year: 2006). Portals and pathways: principles of bacterial toxin entry into host cells. Microbe1, 26–32|
|Blazkova H.,Krejcikova K.,Moudry P.,Frisan T.,Hodny Z.,Bartek J.. (Year: 2010). Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J. Cell. Mol. Med. 14, 357–36710.1111/j.1582-4934.2009.00862.x19650831|
|Boesze-Battaglia K.,Besack D.,McKay T.,Zekavat A.,Otis L.,Jordan-Sciutto K.,et al. (Year: 2006). Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell Microbiol. 8, 823–83610.1111/j.1462-5822.2005.00669.x16611231|
|Cao L.,Bandelac G.,Volgina A.,Korostoff J.,DiRienzo J. M.. (Year: 2008). Role of aromatic amino acids in receptor binding activity and subunit assembly of the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans. Infect. Immun. 76, 2812–282110.1128/IAI.00126-0818426882|
|Cao L.,Volgina A.,Huang C. M.,Korostoff J.,DiRienzo J. M.. (Year: 2005). Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol. Microbiol. 58, 1303–132110.1111/j.1365-2958.2005.04905.x16313618|
|Carette J. E.,Guimaraes C. P.,Varadarajan M.,Park A. S.,Wuethrich I.,Godarova A.,et al. (Year: 2009). Haploid genetic screens in human cells identify host factors used by pathogens. Science326, 1231–123510.1126/science.117895519965467|
|Ciccarelli F. D.,Doerks T.,Von Mering C.,Creevey C. J.,Snel B.,Bork P.. (Year: 2006). Toward automatic reconstruction of a highly resolved tree of life. Science311, 1283–128710.1126/science.112306116513982|
|Cortes-Bratti X.,Chaves-Olarte E.,Lagergård T.,Thelestam M.. (Year: 2000). Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 68, 6903–691110.1128/IAI.68.12.6903-6911.200011083812|
|Cortes-Bratti X.,Karlsson C.,Lagergard T.,Thelestam M.,Frisan T.,Lagergård T.. (Year: 2001). The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276, 5296–530210.1074/jbc.M00852720011076947|
|Cuevas-Ramos G.,Petit C. R.,Marcq I.,Boury M.,Oswald E.,Nougayrède J. P.. (Year: 2010). Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 107, 11537–1154210.1073/pnas.100126110720534522|
|Degnan P. H.,Moran N. A.. (Year: 2008). Diverse phage-encoded toxins in a protective insect endosymbiont. Appl. Environ. Microbiol. 74, 6782–679110.1128/AEM.01285-0818791000|
|Deng K.,Latimer J. L.,Lewis D. A.,Hansen E. J.. (Year: 2001). Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi. Biochem. Biophys. Res. Commun. 285, 609–61510.1006/bbrc.2001.522311453636|
|Dlakic M.. (Year: 2001). Is CdtB a nuclease or a phosphatase?Science291, 54710.1126/science.291.5504.547a11158662|
|Elwell C.,Chao K.,Patel K.,Dreyfus L.. (Year: 2001). Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69, 3418–342210.1128/IAI.69.5.3418-3422.200111292766|
|Elwell C. A.,Dreyfus L. A.. (Year: 2000). DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37, 952–96310.1046/j.1365-2958.2000.02070.x10972814|
|Eshraghi A.,Maldonado-Arocho F. J.,Gargi A.,Cardwell M. M.,Prouty M. G.,Blanke S. R.,et al. (Year: 2010). Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J. Biol. Chem. 285, 18199–1820710.1074/jbc.M110.11291220385557|
|Fox J. G.,Rogers A. B.,Whary M. T.,Ge Z.,Taylor N. S.,Xu S.,et al. (Year: 2004). Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72, 1116–112510.1128/IAI.72.2.1116-1125.200414742559|
|Frisan T.,Cortes-Bratti X.,Chaves-Olarte E.,Stenerlow B.,Thelestam M.. (Year: 2003). The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol. 5, 695–70710.1046/j.1365-2958.2000.02070.x12969375|
|Ge Z.,Feng Y.,Whary M. T.,Nambiar P. R.,Xu S.,Ng V.,et al. (Year: 2005). Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect. Immun. 73, 3559–356710.1128/IAI.73.6.3559-3567.200515908385|
|Ge Z.,Rogers A. B.,Feng Y.,Lee A.,Xu S.,Taylor N. S.,et al. (Year: 2007). Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 9, 2070–208010.1111/j.1462-5822.2007.00939.x17441986|
|Grivennikov S. I.,Greten F. R.,Karin M.. (Year: 2010). Immunity, inflammation, and cancer. Cell140, 883–89910.1016/j.cell.2010.01.02520303878|
|Guerra L.,Carr H. S.,Richter-Dahlfors A.,Masucci M. G.,Thelestam M.,Frost J. A.,et al. (Year: 2008). A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS ONE3:e2254.10.1371/journal.pone.000225418509476|
|Guerra L.,Nemec K. N.,Massey S.,Tatulian S. A.,Thelestam M.,Frisan T.,et al. (Year: 2009). A novel mode of translocation for cytolethal distending toxin. Biochim. Biophys. Acta1793, 489–49510.1016/j.bbamcr.2008.11.01719118582|
|Guerra L.,Teter K.,Lilley B. N.,Stenerlow B.,Holmes R. K.,Ploegh H. L.,et al. (Year: 2005). Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol. 7, 921–93410.1111/j.1462-5822.2005.00520.x15953025|
|Haghjoo E.,Galan J. E.,Galán J. E.. (Year: 2004). Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc. Natl. Acad. Sci. U.S.A. 101, 4614–461910.1073/pnas.040093210115070766|
|Hassane D. C.,Lee R. B.,Mendenhall M. D.,Pickett C. L.. (Year: 2001). Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect. Immun. 69, 5752–575910.1128/IAI.69.9.5752-5759.200111500452|
|Hontz J. S.,Villar-Lecumberri M. T.,Potter B. M.,Yoder M. D.,Dreyfus L. A.,Laity J. H.. (Year: 2006). Differences in crystal and solution structures of the cytolethal distending toxin B subunit: relevance to nuclear translocation and functional activation. J. Biol. Chem. 281, 25365–2537210.1074/jbc.M60372720016809347|
|Hu X.,Stebbins C. E.. (Year: 2006). Dynamics and assembly of the cytolethal distending toxin. Proteins65, 843–85510.1002/prot.2116717034038|
|Jinadasa R. N.,Bloom S. E.,Weiss R. S.,Duhamel G. E.. (Year: 2011). Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology157, 1851–187510.1099/mic.0.049536-021565933|
|Johnson W. M.,Lior H.. (Year: 1988a). A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb. Pathog. 4, 103–11310.1016/0882-4010(88)90052-62849027|
|Johnson W. M.,Lior H.. (Year: 1988b). A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 4, 115–1262849028|
|Karin M.,Lawrence T.,Nizet V.. (Year: 2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell124, 823–83510.1016/j.cell.2006.02.01616497591|
|Kitagawa T.,Hoshida H.,Akada R.. (Year: 2007). Genome-wide analysis of cellular response to bacterial genotoxin CdtB in yeast. Infect. Immun. 75, 1393–140210.1128/IAI.01321-0617220322|
|Lara-Tejero M.,Galan J. E.. (Year: 2000). A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science290, 354–35710.1126/science.290.5490.35411030657|
|Lara-Tejero M.,Galan J. E.. (Year: 2001). CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69, 4358–436510.1128/IAI.69.7.4358-4365.200111401974|
|Lee R. B.,Hassane D. C.,Cottle D. L.,Pickett C. L.. (Year: 2003). Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 71, 541–54512496208|
|Lewis D. A.,Stevens M. K.,Latimer J. L.,Ward C. K.,Deng K.,Blick R.,et al. (Year: 2001). Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect. Immun. 69, 5626–563410.1128/IAI.69.9.5626-5634.200111500438|
|Li L.,Sharipo A.,Chaves-Olarte E.,Masucci M. G.,Levitsky V.,Thelestam M.,et al. (Year: 2002). The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol. 4, 87–9910.1046/j.1462-5822.2002.00174.x11896765|
|Mao X.,DiRienzo J. M.. (Year: 2002). Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol. 4, 245–25510.1046/j.1462-5822.2002.00186.x11952641|
|Matangkasombut O.,Wattanawara-porn R.,Tsuruda K.,Ohara M.,Sugai M.,Mongkolsuk S.. (Year: 2010). Cytolethal distending toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase-independent death in a Saccharomyces cerevisiae model. Infect. Immun. 78, 783–79210.1128/IAI.00857-0919995894|
|McSweeney L. A.,Dreyfus L. A.. (Year: 2004). Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol. 6, 447–45810.1111/j.1462-5822.2004.00373.x15056215|
|McSweeney L. A.,Dreyfus L. A.. (Year: 2005). Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect. Immun. 73, 2051–206010.1128/IAI.73.4.2051-2060.200515784546|
|Mise K.,Akifusa S.,Watarai S.,Ansai T.,Nishihara T.,Takehara T.. (Year: 2005). Involvement of ganglioside GM3 in G(2)/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 73, 4846–485210.1128/IAI.73.8.4846-4852.200516040998|
|Moran N. A.,Degnan P. H.,Santos S. R.,Dunbar H. E.,Ochman H.. (Year: 2005). The players in a mutualistic symbiosis: insects, bacteria, viruses, and virulence genes. Proc. Natl. Acad. Sci. U.S.A. 102, 16919–1692610.1073/pnas.050702910216195380|
|Nesiæ D.,Hsu Y.,Stebbins C. E.,Nesic D.. (Year: 2004). Assembly and function of a bacterial genotoxin. Nature429, 429–43310.1038/nature0253215164065|
|Nesic D.,Stebbins C. E.. (Year: 2005). Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT. PLoS Pathog. 1:e28.10.1371/journal.ppat.001002816304609|
|Nishikubo S.,Ohara M.,Ueno Y.,Ikura M.,Kurihara H.,Komatsuzawa H.,et al. (Year: 2003). An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J. Biol. Chem. 278, 50671–5068110.1074/jbc.M30506220012947116|
|Ochman H.,Lawrence J. G.,Groisman E. A.. (Year: 2000). Lateral gene transfer and the nature of bacterial innovation. Nature405, 299–30410.1038/3501250010830951|
|Oliver K. M.,Moran N. A.,Hunter M. S.. (Year: 2005). Variation in resistance to parasitism in aphids is due to symbionts not host genotype. Proc. Natl. Acad. Sci. U.S.A. 102, 12795–1280010.1073/pnas.050613110216120675|
|Pickett C. L.,Cottle D. L.,Pesci E. C.,Bikah G.. (Year: 1994). Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62, 1046–10518112838|
|Polk D. B.,Peek R. M.. (Year: 2010). Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer10, 403–41410.1038/nrc285720495574|
|Rabin S. D. P.,Flitton J. G.,Demuth D. R.. (Year: 2009). Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces apoptosis in non-proliferating macrophages by a phosphatase-independent mecha-nism. Infect. Immun. 77, 3161–316910.1128/IAI.01227-0819470743|
|Raptis S.,Bapat B.. (Year: 2006). Genetic instability in human tumors. EXS96, 303–32016383024|
|Saiki K.,Gomi T.,Konishi K.. (Year: 2004). Deletion and purification studies to elucidate the structure of the Actinobacillus actinomycetemcomitans cytolethal distending toxin. J. Biochem. 136, 335–34210.1093/jb/mvh12115598890|
|Saiki K.,Konishi K.,Gomi T.,Nishihara T.,Yoshikawa M.. (Year: 2001). Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiol. Immunol. 45, 497–50611497226|
|Sato T.,Koseki T.,Yamato K.,Saiki K.,Konishi K.,Yoshikawa M.,et al. (Year: 2002). p53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G(2) cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 70, 528–53410.1128/IAI.70.2.528-534.200211796579|
|Scott D. A.,Kaper J. B.. (Year: 1994). Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62, 244–2518262635|
|Sert V.,Cans C.,Tasca C.,Bret-Bennis L.,Oswald E.,Ducommun B.,et al. (Year: 1999). The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene18, 6296–630410.1038/sj.onc.120300710597228|
|Shenker B. J.,Besack D.,McKay T.,Pankoski L.,Zekavat A.,Demuth D. R.. (Year: 2004). Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J. Immunol. 172, 410–41714688349|
|Shenker B. J.,Dlakic M.,Walker L. P.,Besack D.,Jaffe E.,LaBelle E.,et al. (Year: 2007). A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3, 4, 5-triphosphate phosphatase activity. J. Immunol. 178, 5099–510817404292|
|Shenker B. J.,Hoffmaster R. H.,McKay T. L.,Demuth D. R.. (Year: 2000). Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells. J. Immunol. 165, 2612–261810946289|
|Solnick J. V.,Vandamme P.. (Year: 2001). Taxonomy of the Helicobacter Genus. Helicobacter pylori: Physiology and Genetics, Chapter 5. Washington, DC: ASM Press|
|Spanò S.,Ugalde J. E.,Galán J. E.. (Year: 2008). Delivery of a Salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe3, 30–3810.1016/j.chom.2007.11.00118191792|
|Toprak N. U.,Yagci A.,Gulluoglu B. M.,Akin M. L.,Demirkalem P.,Celenk T.,et al. (Year: 2006). A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12, 782–78610.1111/j.1469-0691.2006.01494.x16842574|
|Touati E.,Michel V.,Thiberge J. M.,Wuscher N.,Huerre M.,Labigne A.. (Year: 2003). Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology124, 1408–141910.1016/S0016-5085(03)00266-X12730880|
|Vandamme P.,Falsen E.,Rossau R.,Hoste B.,Segers P.,Tytgat R.,et al. (Year: 1991). Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int. J. Syst. Bacteriol. 41, 88–10310.1099/00207713-41-1-881704793|
|Vogelmann R.,Amieva M. R.. (Year: 2007). The role of bacterial pathogens in cancer. Curr. Opin. Microbiol. 10, 76–8110.1016/j.mib.2006.12.00417208515|
|Wising C.,Svensson L. A.,Ahmed H. J.,Sundaeus V.,Ahlman K.,Jonsson I. M.,et al. (Year: 2002). Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb. Pathog. 33, 49–6210.1006/mpat.2002.051612202104|
|Yamada T.,Komoto J.,Saiki K.,Konishi K.,Takusagawa F.. (Year: 2006). Variation of loop sequence alters stability of cytolethal distending toxin (CDT): crystal structure of CDT from Actinobacillus actinomycetemcomitans. Protein Sci. 15, 362–37210.1110/ps.05179050616434747|
|Yamamoto K.,Tominaga K.,Sukedai M.,Okinaga T.,Iwanaga K.,Nishihara T.,et al. (Year: 2004). Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur. J. Oral Sci. 112, 445–45110.1111/j.1600-0722.2004.00157.x15458505|
|Yarza P.,Ludwig W.,Euzéby J.,Amann R.,Schleifer K.-H.,Glöckner F. O.,et al. (Year: 2010). Update of the all-species living tree project based on 16S and 23S rRNA sequence analyses. Syst. Appl. Microbiol. 33, 291–29910.1016/j.syapm.2010.08.00120817437|
Keywords: cytolethal distending toxin, CDT, cell cycle arrest, bacterial toxin, genotoxin, cyclomodulin.
Previous Document: Toll-like receptor sensing of human herpesvirus infection.
Next Document: Action Potential Propagation Through Tissue Lacking Gap Junctions: Application to Engrafted Cells in...